Leerink analyst Danielle Antalffy raised her price target for Insulet to $130 from $100 after the company announced that Patrick Sullivan would be stepping down as CEO at the end of this year, passing the baton to current COO Shacey Petrovic on January 1, 2019. The analyst believes this transition indicates that Insulet fundamentals are stronger than ever. In conjunction with the announcement, the company also reiterated full year 2018 sales guidance of $547M-$562M, she adds. Antalffy reiterates an Outperform rating on the shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.